Τόμος 21 (2007) – Τεύχος 3 – Άρθρο 5 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 21 (2007) – Issue 3 – Article 5 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Vaccination coverage of nursing staff against hepatitis B and information source about hepatitis prevention: a study in a regional teaching hospital
Authors M. Noula¹, D. Mastrogiannis¹, M. Mantzorou², Ch. Chouridou³ and A. Deltsidou¹

1. Nursing Department, High Technological Educational Institution of Lamia, Lamia, Greece

2. NIMITS Hospital, Athens, Greece

3. Registered Nurse, Athens, Greece

Citation Noula, M., Mastrogiannis, D., Mantzorou, M., Chouridou, Ch., Mavreas, A.: Vaccination coverage of nursing staff against hepatitis B and information source about hepatitis prevention: a study in a regional teaching hospital, Epitheorese Klin. Farmakol. Farmakokinet. 21(3): 271-277 (2007)
Publication Date Accepted for publication (Final version): September 10, 2007
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Vaccination coverage, nursing staff, immunization, hepatitis B and information source.
Other Terms review article
Summary The aim of this epidemiological studywas to define the prevalence of immunization against Hepatitis B (HB) and to investigate the factors that may influence the vaccination coverage of the nursing staff (NS) in a regional teaching hospital. In this study the prevalence of HbsAg, positivity of antibodies against HB in blood samples as well as the prevalence of vaccination of the NS, have been recorded. All participants filled out a specific questionnaire. Ninety six per cent of the sample (n=144) reported having being tested for HBsAg without prior vaccination and 2.8% (n=4) of these were found HbsAg positive, 15.7% (n=21) had antibodies against HB, 3.3% (n=5) had already been infected with HB, and 77.3% (n=116) were vaccinated. The main factor that contributed to the performance of the vaccine was prevention (98.3%, n=114/116). Regarding the reason why they hadn’t been vaccinated, 22.2% (n=4) stated they were afraid of the adverse effects, 11.1% (n=2) reported health reasons, 61.1% (n=11) already had antibodies and 5.6%  (n=1) were infected with HB. The majority of participants (58.3%, n=74) reported they were informed about HB during first degree training, 15.7% (n=12) by the Committee of Nosocomial Infections, 7.1% (n=9) by leaflets administered by the Ministry of Health, 13.4% (n=17) by friends or relatives and (4.7% (n=6) through the mass media. From the findings of the present study it is obvious that there is a need to educate health care workers to take all the precautions against hepatitis B infection during any invasive procedures. It is also considered essential to provide counseling, adequate support and retraining services for the prevention of the disease.
References 1. Da Villa G., Picciotto L., Elia S., Peluso F., Montanaro F., Maisto T.: Hepatitis B vaccination: Universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field. Vaccine 13: 1240-1243 (1995)

2. Krahn M., Detsky A.S.: Should Canada and the United States Universally Vaccinate Infants against Hepatitis B? A Cost-Effectiveness Analysis.  Med.  Decis.  Making 13(1): 4-20 (1993)

3. Andre F.E., Zukerman A.J.: Review: Protective efficacy of hepatitis vaccines in neonates. J. Med. Virol. 44: 144- 151 (1994)

4. Krahn M.D., Detsky A.S.: Universal hepatitis B vacci- nation: the economics of prevention (editorial).  CMAJ 146: 19-21 (1992)

5. Zuckerman A.J., Lavanchy D.: Treatment options for chronic hepatitis. BMJ 319: 799-800 (1999)

6.  Kattamis Ch.: Vaccines against hepatitis. Proceedings of 21st National Annual Medical Conference. Pp.72-80, Athens, Greece, 1995

7. Pavlakou A.A.: Specific infections. What new in anesthesia 1995-1998. Proceedings of 7th Panhellenic Seminar in Anesthesiology. Pp.201-212, Athens, Greece, 1999

8. Bonanni P.: Report on Working Group 1: Albania, Andora, Canada, France, Italy, Portugal, Poland, Romania and Spain. Vaccine 16 (Suppl.): S58-S60 (1998)

9. Grob P.J.: Report on Working Group 2: Austria, Belgium, Bulgaria, Germany, Greece, Hungary, Malta, Russia, Switzerland, Turkey and Uzbekistan. Vaccine16 (Suppl.): S61-S62 (1998)

10. Melnick J.L.: International prospects for combined vaccines with emphasis on quadrivalent diphtheria-tetanus-petrussis-hepatitis B vaccine. Ann. N.Y. Acad. Sci.754: 267-272 (1995)

11. Zuckerman A.J.: Developing new hepatitis B immunization strategies. Gut 38 (Suppl. 2): S60-S62 (1996)

12. European Parliament Committee on Social Affairs: Employment Report on vaccination of health care workers and  other at risk occupations against hepatitis B. Session Document A300027/93, p.23, 27 January 1993

13. Greene E.S., Berry A.J., Arnold W.P.3rd, Jagger J.: Percutaneous injuries in anesthesia personnel. Anesth. Analg. 83: 273-278 (1996)

14. WHO: Expanded Programme on immunization Global Advisory Group. Weekly Epidemiol. Record 3: 11-16 (1992)

15. Gerberding J.L.: The infected health care provider. N. Engl. J. Med. 334: 594-595 (1996)

16. Cunningham S.M., Cunningham R., Izmeth M.G., Baker B., Hart C.A.: Seroprevalence of hepatitis B and C in Merseyside hospital for the mentally handicapped. Epidemiol. Infect. 112 (1): 195-200 (1994)

17. Noula M., Theodosopoulou E., Margari N., Gesouli E., Amari M., Iordanou P.: Immunologic status of nursing personnel against hepatitis B virus. Epith. Klin. Farmakol. Farmakokinet. 20: 37-44 (2002)

18. Kondili L.A., Ulqinaku D., Hajdini M., Basho M., Chionne P., Madonna E., Taliani G., Candido A., Dentico P., Bino S., Rapicetta M.: Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection. Infection 35: 94-97 (2007)

19. de Vries B., Cossart Y.E.: Needlestick injury in medical students. Med. J. Aust. 160: 398-400 (1994)

20. Hsieh W.B., Chiu N.C., Lee C.M., Huang F.Y.: Occupational blood and infectious body fluid exposures in a teaching hospital: a three year review. J. Microbiol. Immunol. Infect. 39: 321-327 (2006)

21. Perdikaris P., Anthousi A., Amanatidou A., Papaevaggelou G.: Attitudes of Greek physicians regarding general vaccination and hepatitis B. Arch. Hellenic Med. 17: 593-599 (2000)

22. Noula M., Theodosopoulou E., Iordanou P., Lavdaniti M., Kotrotsiou E., Ammari M., Konstantinou E.: Frequency of vaccination against Hepatitis B in the Nursing Personnel. Rev. Clin. Pharmacol. Pharmacokinet. (Int. Ed.) 16: 141-148 (2002)

23. Kastanis G., Chatzigeorgiou D., Tzavara O., Markou N.: How sensitive is the personnel of a hospital regarding HBV, TB and tetanus vaccination? Proceedings of 4th National Conference of Infections and Hygiene in Hospital environment. P. 54, Athens, Greece, 1997

24. Rachiotis G., Goritsas C., Alikakou V., Ferti A., Roumeliotou A.: Vaccination against hepatitis B virus in workers of a general hospital in Athens. Med. Lav. 96(1): 80-86 (2005)

25. Hallauer J.: VHPB: Summary of strategies and recommendation. Viral Hepatitis Prevention Board. Vaccine 13 (Suppl. 1): S61-S63 (1995)

26. Kosgeroglou N., Ayranci U., Vardareli E., Dincer S.: Occupational exposure to hepatitis infection among Turkish nurses: frequency of needle exposure, sharps injuries and vaccination. Epidemiol. Infect. 132(1): 27-33 (2004)

27. Oh H.S., Yi S.E., Choe K.W.: Epidemiological characteristics of occupational blood exposures of healthcare workers in a university hospital in South Korea for 10 years. J. Hosp. Infect. 60: 269-275 (2005)

28. Gyawali P, Rice P.S., Tilzey A.J.: Exposure to blood borne viruses and the hepatitis B vaccination status among healthcare workers in inner London. Occup. Environ. Med. 55: 570-572 (1998)

29. Talaat M., Kandeel A., El-Shoubary W., Bodenschatz C., Khairy I., Oun S., Mahoney F.J.: Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. Am. J. Infect. Control 31: 469-474 (2003)

30. RECOMBIVAX VACCINE, MSD & ENGERIX-B VACCINE. Smithkline Beecham Biological SA. In Greek National Formulary, EOF Edition, Athens, Pp.597-598 (2000)

31. Noula M., Iordanou P., Gessouli E., Evaggelou E.: The nurses awareness of the occupational risk regarding hepatitis B. ICUs Nursing Web J. 10th Issue: 1-16 (2002)

32. Noula M., Iordanou P., Gesouli E., Margari N., Vardaki Z.: Knowledge of nursing staff about the methods of HBV transmission and occupational hazards. Medical Annals 24: 435-439 (2001)

33. Gessouli-Voltiraki E., Tsetsekou E., Koutrouba P., Vompiris G., Vourdaha- Vompiri E.: Vaccination coverage of Health Care Professional against Hepatitis B. Medical Annals 30: 177-183 (2007)

34. Gessouli-Voltiraki E., Koutrouba P., Vompiris G., Deltsidou A.: HBV immunization status of health care personnel: a study in two Greek regional hospitals. Rev. Clin.  Pharmacol.  Pharmakinet.  (Int.  Ed.)  21:  197-202 (2007)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2007 – ANNUAL SUBSCRIPTION 2007
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

Bookmark the permalink.

Comments are closed.